Author

N. Matulionis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:metabolism & bioenergetics· 2 Assay:metabolomics· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

H. R. Christofk· 2 shared A. Delcourt· 1 shared A. Jones· 1 shared A. Nakano· 1 shared A. Petcherski· 1 shared A. Pfeiffer· 1 shared A. S. Divakaruni· 1 shared A. S. Goldstein· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

H. R. Christofk

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer

P. Crowell, J. Giafaglione, A. Jones, N. Nunley, T. Hashimoto, A. Delcourt, A. Petcherski, M. Bernard, R. R. Huang, J.-Y. Low, N. Matulionis, X. Guan, N. Navone, J. Alumkal, M. Haffner, , A. S. Goldstein

This study shows that androgen receptor inhibition in prostate cancer cells shifts metabolism to oxidative mitochondrial pathways and increases sensitivity to complex I inhibitors.

Cell Reports · Oct 1, 2023Peer-reviewedCancer Biology

Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy

C. A. Perez-Ramirez, H. Nakano, R. C. Law, N. Matulionis, J. Thompson, A. Pfeiffer, J. O. Park, A. Nakano, H. R. Christofk

The paper maps fetal metabolism during mid-to-late gestation in normal and diabetic pregnancies, identifying metabolic changes due to maternal hyperglycemia.

bioRxiv · Mar 16, 2023Cell Biology

FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer

B. R. Wilde, N. Chakraborty, N. Matulionis, S. Hernandez, D. Ueno, M. E. Gee, E. D. Esplin, K. Ouyang, K. Nykamp, B. Shuch, H. R. Christofk

This paper functionally characterizes FH variants of uncertain significance and identifies purine salvage pathway dependence as a targetable vulnerability in FH-deficient kidney cancer.

bioRxiv · Aug 15, 2022Cancer Biology